ANAB Total Utang marang Modal AnaptysBio Inc.

Lambang korporat lan logo AnaptysBio, Inc. (ANAB)

The stability of AnaptysBio, Inc. (ANAB) is confirmed by its resilience to geopolitical supply risks, as evidenced by the ratio of total liabilities to equity. The operational base relies on the drive for efficiency within the crowded immunotherapy sector, while the patent moat and FDA requirements block new entrants. The value of 26.79 serves as the final mark for this leverage metric.

ANAB: Total Utang marang Modal AnaptysBio 04.07.2022 - 28.10.2026

Rincian analitis lan laporan data perusahaan AnaptysBio Inc. (ANAB)

- rega lan prakiraan konsensus rega:
Bagan rega AnaptysBio|ANAB - Bagan tingkat prakiraan
- data kapitalisasi pasar:
Kapitalisasi pasar AnaptysBio|ANAB - Nilai Dipunlarasaken Utang lan Kas
- data kapitalisasi buku:
Nilai Buku saben Saham AnaptysBio|ANAB - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku anaptysbio.com|ANAB - Nilai Agregat Aset
- data utang lan likuiditas:
Utang marang Ekuitas AnaptysBio, Inc.|ANAB - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal AnaptysBio, Inc.|ANAB - Gunggung utang perusahaan|Utang marang nilai buku AnaptysBio|ANAB - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan AnaptysBio
Analisis komprehensif perusahaan:ANAB - AnaptysBio
Produk merek AnaptysBio Inc.

In the biotechnology sector, the balance of borrowed funds determines the stability of new drug development. The ratio compares total liabilities to net assets, measuring the degree of financial leverage. Analyzing total debt relative to equity reveals the company's deleveraging pace. This is critical for AnaptysBio, Inc. (ANAB), as royalties from Jemperli allow the company to fund its immune pipeline without excessive loans. Low indebtedness minimizes risks during the scaling of Phase 2.

Pesaing utama

Utang marang Ekuitas argenx ARGX|Utang Agregat marang Ekuitas BioNTech Inc.|Abivax SA (ABVX) - Total Utang marang Modal|Rasio Kabeh Utang marang Dana Pribadi ADMA Corp (ADMA)|Total Utang marang Modal PTGX (Protagonist Therapeutics)|immunovant.com - Total Utang marang Modal|Utang marang Ekuitas Kiniksa (KNSA)|GRFS: Rasio Kabeh Utang marang Dana Pribadi|ADPT (Adaptive Biotechnologies Corp) - Utang marang Ekuitas|Celldex Corp (CLDX) - Rasio Total Utang marang Ekuitas|AUPH (Aurinia Pharmaceuticals) - Total Utang marang Modal|Total Utang marang Modal biocryst.com (BCRX)|Vera Therapeutics (VERA) - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi Dianthus Therapeutics Inc (DNTH)|Total Utang marang Modal PHVS|AbCellera - Koefisien Total Utang marang Modal|TRML: Utang marang Ekuitas|PGEN: Rasio Total Utang marang Ekuitas|PHAR (Pharming Group) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Nektar Therapeutics Inc|UPB (Upstream Bio Corp) - Rasio Total Utang marang Ekuitas|Total Utang marang Modal ZBIO|Utang marang Ekuitas Immunome, Inc. IMNM|Rasio Utang marang Ekuitas gossamerbio.com (GOSS)|KALV: Total Utang marang Modal|Utang marang Modal Septerna, Inc. SEPN|Pieris Pharmaceuticals Inc - Total Utang marang Modal|SVRA: Total Utang marang Modal|Utang marang Ekuitas Rigel Pharmaceuticals|astriatx.com (ATXS) - Rasio Utang marang Ekuitas|ENGN (enGene) - Total Utang marang Modal|Total Utang marang Modal RAPT|JBIO - Utang marang Ekuitas|Utang Agregat marang Ekuitas Aclaris Therapeutics, Inc ACRS|Rasio Total Utang marang Ekuitas Kyverna Therapeutics (KYTX)|TLSA - Utang Agregat marang Modal|CABA (Cabaletta Bio) - Rasio Total Utang marang Ekuitas|VTYX: Utang marang Modal|Theratechnologies Inc - Utang marang Ekuitas|Avalo Therapeutics Inc (AVTX) - Koefisien Total Utang marang Modal|Total Utang marang Modal Eledon Pharmaceuticals|Utang marang Ekuitas agenusbio.com|CLYM (Climb Bio) - Total Utang marang Modal|Koefisien Total Utang marang Modal ZURA (Zura Bio Ltd)|ATYR: Utang marang Ekuitas|ADAG - Utang marang Modal|Rasio Total Utang marang Ekuitas Ikena Oncology, Inc. (IMA)|STTK - Rasio Kabeh Utang marang Dana Pribadi|equilliumbio.com - Total Utang marang Modal|CNTB (Connect Biopharma Holdings Limited) - Koefisien Total Utang marang Modal|Utang marang Ekuitas Immunic Therapeutics (IMUX)|Rasio Utang marang Ekuitas Atara Biotherapeutics Inc|Total Utang marang Modal IFRX (InflaRx N.V.)|Rasio Total Utang marang Ekuitas x4pharma.com XFOR|Rasio Total Utang marang Ekuitas ACET|Koefisien Total Utang marang Modal Celularity Inc CELU|INmune Bio Corp - Total Utang marang Modal|BRNS: Total Utang marang Modal|Utang marang Ekuitas Kezar Life Sciences|sabbiotherapeutics.com (SABS) - Rasio Utang marang Ekuitas|AKTX (Akari Therapeutics Plc) - Total Utang marang Modal|Total Utang marang Modal Enlivex Therapeutics, Ltd.|Total Utang marang Modal Q32 Bio Inc. (QTTB)|Utang marang Ekuitas GOVX (GeoVax Corp)|Edesa Biotech, Inc. (EDSA) - Utang marang Ekuitas|Utang Agregat marang Ekuitas ibioinc.com IBIO|Total Utang marang Modal Carisma Tx (CARM)|XTLB - Rasio Kabeh Utang marang Dana Pribadi|BOLT: Total Utang marang Modal|HCWB (HCW Biologics) - Total Utang marang Modal|APVO - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi AIM|Utang marang Ekuitas ADTX (Aditxt)|Rasio Total Utang marang Ekuitas GRI Bio Inc (GRI)|Total Utang marang Modal XRTX (XORTX)|HIND - Total Utang marang Modal|Rasio Total Utang marang Ekuitas Revelation Biosciences (REVB)|INDP - Rasio Kabeh Utang marang Dana Pribadi|Scinai Immunotherapeutics Ltd. - Total Utang marang Modal|CALI (CalciMedica) - Koefisien Total Utang marang Modal|Utang marang Ekuitas AFMD|Rasio Total Utang marang Ekuitas ALLK|Utang marang Ekuitas HOOK (HOOKIPA Pharma Inc.)|Rasio Total Utang marang Ekuitas igmbio.com IGMS|Rasio Total Utang marang Ekuitas ITOS (iTeos Therapeutics, Inc.)|Ocean Biomedical Inc - Total Utang marang Modal|TC BioPharm (Holdings) PLC (TCBP) - Utang marang Ekuitas|THRD - Rasio Utang marang Ekuitas